These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 25022336

  • 1. Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8(+) T cell memory.
    Eberstål S, Fritzell S, Sandén E, Visse E, Darabi A, Siesjö P.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):161-7. PubMed ID: 25022336
    [Abstract] [Full Text] [Related]

  • 2. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
    Smith KE, Fritzell S, Badn W, Eberstål S, Janelidze S, Visse E, Darabi A, Siesjö P.
    Int J Cancer; 2009 Feb 01; 124(3):630-7. PubMed ID: 18972433
    [Abstract] [Full Text] [Related]

  • 3. Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
    Eberstål S, Sandén E, Fritzell S, Darabi A, Visse E, Siesjö P.
    Int J Cancer; 2014 Jun 01; 134(11):2748-53. PubMed ID: 24243648
    [Abstract] [Full Text] [Related]

  • 4. Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
    Ströjby S, Eberstål S, Svensson A, Fritzell S, Bexell D, Siesjö P, Darabi A, Bengzon J.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):240-3. PubMed ID: 25086876
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
    Eberstål S, Badn W, Fritzell S, Esbjörnsson M, Darabi A, Visse E, Siesjö P.
    Cancer Immunol Immunother; 2012 Aug 15; 61(8):1191-9. PubMed ID: 22213142
    [Abstract] [Full Text] [Related]

  • 6. Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma.
    Smith KE, Janelidze S, Visse E, Badn W, Salford L, Siesjö P, Darabi A.
    Int J Cancer; 2007 Jan 01; 120(1):75-80. PubMed ID: 17044023
    [Abstract] [Full Text] [Related]

  • 7. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
    Janelidze S, Bexell D, Badn W, Darabi A, Smith KE, Fritzell S, Gunnarsson S, Milos P, Bengzon J, Salford LG, Siesjö P, Visse E.
    J Immunother; 2009 Jan 01; 32(6):593-601. PubMed ID: 19483650
    [Abstract] [Full Text] [Related]

  • 8. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M, Hofer MJ, Roth E, Pircher HP, Pagenstecher A.
    J Neuropathol Exp Neurol; 2009 May 01; 68(5):525-34. PubMed ID: 19525900
    [Abstract] [Full Text] [Related]

  • 9. Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.
    Badn W, Visse E, Darabi A, Smith KE, Salford LG, Siesjö P.
    J Immunol; 2007 Sep 15; 179(6):4231-8. PubMed ID: 17785863
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
    Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P.
    Scand J Immunol; 2007 Mar 15; 65(3):289-97. PubMed ID: 17309784
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
    El Andaloussi A, Sonabend AM, Han Y, Lesniak MS.
    Glia; 2006 Nov 01; 54(6):526-35. PubMed ID: 16906541
    [Abstract] [Full Text] [Related]

  • 12. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug 01; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 13. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y, Tagawa M, Namba H, Oga M, Kawamura K, Tasaki K, Sakiyama S, Yamaura A.
    Cancer Gene Ther; 2000 Sep 01; 7(9):1263-9. PubMed ID: 11023199
    [Abstract] [Full Text] [Related]

  • 14. IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
    Fritzell S, Eberstål S, Sandén E, Visse E, Darabi A, Siesjö P.
    J Neuroimmunol; 2013 May 15; 258(1-2):91-5. PubMed ID: 23528658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
    Siesjö P, Visse E, Sjögren HO.
    J Immunother Emphasis Tumor Immunol; 1996 Sep 15; 19(5):334-45. PubMed ID: 8941873
    [Abstract] [Full Text] [Related]

  • 18. Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.
    Volovitz I, Marmor Y, Azulay M, Machlenkin A, Goldberger O, Mor F, Slavin S, Ram Z, Cohen IR, Eisenbach L.
    J Immunol; 2011 Nov 15; 187(10):5452-62. PubMed ID: 21998458
    [Abstract] [Full Text] [Related]

  • 19. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.